サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1309737

コラーゲン・ゼラチンの世界市場：供給源別 (ウシ、ブタ、海産物)・用途別 (創傷ケア、整形外科、心血管、歯科、外科、神経修復)・エンドユーザー別 (病院、手術センター)・地域別の将来予測 (2028年まで)

Collagen and Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopaedic, Cardiovascular, Dental, Surgical, Nerve Repair), End User (Hospitals, Surgical Centers), Region - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 234 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.25円
コラーゲン・ゼラチンの世界市場：供給源別 (ウシ、ブタ、海産物)・用途別 (創傷ケア、整形外科、心血管、歯科、外科、神経修復)・エンドユーザー別 (病院、手術センター)・地域別の将来予測 (2028年まで)
出版日: 2023年07月12日
発行: MarketsandMarkets
ページ情報: 英文 234 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のコラーゲン・ゼラチンの市場規模は、予測期間中に6.5%のCAGRで成長し、2023年の12億米ドルから、2028年には16億米ドルに達すると予測されています。

コラーゲンやゼラチンの創傷治療用途への採用の増加や、コラーゲン・ゼラチンの研究への資金提供の増加などの要因が、市場成長の原動力となっています。心臓血管手術の増加も市場成長にプラスの影響を与える見通しです。

"供給源別では、ウシセグメントが予測期間中に圧倒的なシェアを占める"

世界のコラーゲン・ゼラチン市場を供給源別に見ると、ブタ由来のセグメントは2022年に最大のシェアを占めました。これは主に、組織工学におけるその高い広範な使用や、創傷治療用途の生体材料の需要増加によるものです。生体適合性、構造的支持、保湿性など様々な要因により、様々な創傷治療用途でウシ由来コラーゲン製品の使用が増加しています。

"整形外科セグメントは、2022年に用途別で最大のシェアを有する"

世界のコラーゲン・ゼラチン市場を用途別に見ると、整形外科セグメントが2022年に最大のシェアを占めました。このセグメントの優位性は、様々な整形外科手術におけるゼラチン・コラーゲンベース製品の使用の増加や、スキャフォールドの需要増加に起因します。

"アジア太平洋地域がより速いペースで成長する見通し"

世界のコラーゲン・ゼラチン市場を地域別に見ると、アジア太平洋地域が著しいCAGRで成長すると予想されています。この地域の成長は、慢性創傷の有病率の増加と慢性潰瘍に苦しむ人々の数が主な要因です。さらに、コラーゲンベースの創傷ケア製品の需要増加や手術件数の増加が、同地域の成長を加速させる可能性が高いです。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • コラーゲン・ゼラチン市場：企業収益の変化と新たな収益源
  • バリューチェーン分析
  • サプライチェーン
  • コラーゲン・ゼラチン市場：エコシステム分析
  • 技術分析
  • ポーターのファイブフォース分析
  • 規制分析
  • 特許分析
  • 主要な会議とイベント (2023年～2024年)
  • 価格分析
  • 価格分析

第6章 コラーゲン・ゼラチン市場：供給源別

  • イントロダクション
  • ウシ由来コラーゲン・ゼラチン
  • ブタ由来コラーゲン・ゼラチン
  • その他の由来のコラーゲン・ゼラチン

第7章 コラーゲン市場：用途別

  • イントロダクション
  • 整形外科
  • 創傷ケア
  • 歯科
  • 外科
  • 心血管
  • その他の用途

第8章 ゼラチン市場：用途別

  • イントロダクション
  • 整形外科
  • 創傷ケア
  • その他の用途

第9章 コラーゲン・ゼラチン市場：エンドユーザー別

  • イントロダクション
  • 病院
  • 手術センター

第10章 コラーゲン・ゼラチン市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他の欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他のアジア太平洋
  • その他の地域 (ROW)
    • ラテンアメリカ
    • 中東・アフリカ

第11章 競合情勢

  • イントロダクション
  • 主要企業が採用した戦略
  • 収益シェア分析
  • 市場シェア分析
  • 企業評価マトリックス：主要企業
  • 競合ベンチマーキング：上位25社
  • 企業評価マトリックス：スタートアップ/中小企業
  • 競合ベンチマーキング：スタートアップ/中小企業
  • 競争シナリオと動向

第12章 企業プロファイル

  • 主要企業
    • INTEGRA LIFESCIENCES
    • DSM
    • NITTA GELATIN INC.
    • COLLPLANT BIOTECHNOLOGIES LTD.
    • COLLAGEN SOLUTIONS PLC
    • REGENITY
    • SYMATESE
    • GELITA AG
    • TESSENDERLO GROUP (BU PB LINER)
    • SMITH & NEPHEW PLC
    • ZIMVIE INC.
    • JELLAGEN
  • その他の企業
    • ADVANCED BIOMATRIX
    • MATRICEL GMBH
    • ROUSSELOT
    • WEISHARDT
    • XIAMEN HYFINE GELATIN CO., LTD.
    • GEISTLICH PHARMA AG
    • SYNERHEAL PHARMACEUTICALS
    • BIOREGEN TECHNOLOGIES
    • MERIL LIFE SCIENCES PVT. LTD.
    • MEDSKIN SUWELACK
    • COLOGENESIS HEALTHCARE PVT LTD
    • DERMARITE INDUSTRIES, LLC
    • EUCARE PHARMACEUTICALS PRIVATE LIMITED

第13章 付録

目次
Product Code: BT 5488

The global collagen and gelatin market size is projected to reach USD 1.6 billion by 2028 from USD 1.2 billion in 2023, at a CAGR of 6.5% during the forecast period. Factors such as increased adoption of collagen and gelatin in wound care applications coupled with increased funding for collagen and gelatin research is driving the market growth. Increased number of cardiovascular surgeries is further likely to have positive impact on the market growth/

"The bovine segment held the dominant share in the collagen and gelatin market, by source, during the forecast period."

Based on Source, the global collagen and gelatin market is segmented into bovine, porcine, and other sources. The Porcine segment accounted for the largest share in 2022. This is mainly due to the high its extensive use in tissue engineering and increased demand for biomaterials for wound care applications. Owing to various factors such as biocompatibility, structural support, moisture retention and other factors are increasing use of Bovine-based collagen products for various wound care applications.

"Orthopedic segment accounted for the largest share of the application segment in 2022."

Based on application, the global collagen market is segmented into, wound care, dental, orthopedic, surgical, cardiovascular. The global gelatin market is segmented into orthopedic, wound care, and other applications. The orthopedic segment accounted for the largest share of the collagen and gelatin market in 2022. The dominance of the segment is attributable to the increased use of gelatin and collagen based products in various orthopedic surgeries and the increased demand for scaffolds.

"Asia Pacific region is likely to grow at a faster pace."

The collagen and gelatin market is segmented into North America, , Asia Pacific, Europe and Rest of the World. Asia Pacific region is anticipated to grow at a significant CAGR. The growth of the region is majorly driven by the increasing prevalence of chronic wounds and the number of people suffering from chronic ulcers. Furthermore, increased adoption of demand for collagen-based wound care products and a rise in the number of surgeries is likely to upsurge the growth in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70%, and Demand Side - 30%
  • By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:

  • Integra LifeSciences (US)
  • DSM (Netherlands)
  • CollPlant Biotechnologies Ltd. (Israel)
  • Nitta Gelatin Inc. (Japan)
  • Collagen Solutions Ltd. (UK)
  • Collagen Matrix, Inc. (US)
  • Symatese (France)
  • Gelita AG (Germany)
  • Tessenderlo Group ( BU PB Leiner ) (Belgium)
  • Smith & Nephew (UK)
  • ZimVie (US)
  • Jellagen (UK)
  • Advanced BioMatrix (US)
  • Matricel GmbH (Germany)
  • Rousselot (Netherlands)
  • Weishardt (France)
  • Xiamen Hyfine Gelatin (China)
  • Geistlich Pharma AG (Switzerland)
  • Synerheal Pharmaceuticals (India)
  • Bioregen Technologies (India)
  • Meril LifeSciences (India)
  • Medskin Suwelack (Germany)
  • Cologenesis Healthcare Pvt Ltd (India)
  • DermaRite Industries, LLC (US)
  • Eucare Pharmaceuticals Private Limited (India)

Research Coverage:

This report provides a detailed picture of the Collagen and Gelatin market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end-user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall collagen and gelatin market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growing incidence of diabetes, cancer, and chronic wounds, Rising funding and investments for R&D, Growing number of surgical procedures), restraints (Availability of alternate biomaterials), opportunities (Implementation of the 21st Century Cures Act), and challenges (Insufficient processing technologies) influencing the growth of collagen and gelatin market.
  • Product Development/Innovation: Detailed insights on newly launched products of the collagen and gelatin market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the collagen and gelatin market across varied regions.
  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the collagen and gelatin market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players. Integra LifeSciences (US), DSM (Netherlands), CollPlant Biotechnologies Ltd. (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions Ltd. (UK), and among others in the collagen and gelatin market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 COLLAGEN AND GELATIN MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 COLLAGEN AND GELATIN MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 COLLAGEN AND GELATIN MARKET SIZE ESTIMATION, 2022
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
    • FIGURE 5 ILLUSTRATIVE EXAMPLE OF INTEGRA LIFESCIENCES: REVENUE SHARE ANALYSIS, 2022
    • 2.2.1 INSIGHTS FROM PRIMARIES
    • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY EXPERTS
    • 2.2.2 SEGMENTAL ASSESSMENT (BY SOURCE, APPLICATION, AND END USER): TOP-DOWN APPROACH
    • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.3 GROWTH RATE ASSUMPTIONS
    • FIGURE 8 COLLAGEN AND GELATIN MARKET: CAGR PROJECTIONS, 2023-2028
    • FIGURE 9 COLLAGEN AND GELATIN MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 IMPACT OF RECESSION ON COLLAGEN AND GELATIN MARKET
    • TABLE 1 GLOBAL INFLATION RATE, 2021-2028 (%)
    • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
    • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

    • FIGURE 11 COLLAGEN AND GELATIN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 COLLAGEN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 GELATIN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 COLLAGEN AND GELATIN MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 REGIONAL SNAPSHOT OF COLLAGEN AND GELATIN MARKET

4 PREMIUM INSIGHTS

  • 4.1 GROWTH OPPORTUNITIES FOR PLAYERS IN COLLAGEN AND GELATIN MARKET
    • FIGURE 16 INCREASED PREVALENCE OF DIABETES AND CANCER TO DRIVE MARKET
  • 4.2 COLLAGEN AND GELATIN MARKET IN NORTH AMERICA, BY SOURCE AND COUNTRY, 2022
    • FIGURE 17 BOVINE AND US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN COLLAGEN AND GELATIN MARKET, BY SOURCE AND COUNTRY, RESPECTIVELY, IN 2022
  • 4.3 COLLAGEN AND GELATIN MARKET SHARE, BY SOURCE, 2023 VS. 2028
    • FIGURE 18 BOVINE SEGMENT TO DOMINATE MARKET IN 2028
  • 4.4 COLLAGEN AND GELATIN MARKET SHARE, BY END USER, 2022
    • FIGURE 19 HOSPITALS SEGMENT HELD LARGER MARKET SHARE IN 2022
  • 4.5 COLLAGEN AND GELATIN MARKET GROWTH OPPORTUNITIES, BY COUNTRY, 2023-2028
    • FIGURE 20 JAPAN TO REGISTER SECOND-HIGHEST CAGR IN COLLAGEN MARKET FROM 2023 TO 2028
    • FIGURE 21 CHINA TO EXHIBIT HIGHEST CAGR IN GELATIN MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 COLLAGEN AND GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 4 COLLAGEN AND GELATIN MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing prevalence of diabetes & chronic wounds and cancer
      • 5.2.1.2 Rising investments and funding in R&D of collagen and gelatin products
      • 5.2.1.3 Growing number of surgical procedures
    • TABLE 5 NUMBER OF SURGERIES PERFORMED IN US, 2022-2023
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Availability of alternative biomaterials to collagen and gelatin
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Enforcement of 21st Century Cures Act
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of advanced manufacturing and marketing technologies
  • 5.3 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR PLAYERS IN COLLAGEN AND GELATIN MARKET
    • FIGURE 23 INCREASED USE OF COLLAGEN AND GELATIN PRODUCTS IN WOUND CARE AND SURGICAL PROCEDURES IS LIKELY TO HAVE POSITIVE IMPACT ON THE GROWTH OF THE MARKET
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 24 COLLAGEN AND GELATIN MARKET: VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN
    • FIGURE 25 SUPPLY CHAIN OF COLLAGEN & GELATIN MARKET
  • 5.6 COLLAGEN AND GELATIN MARKET: ECOSYSTEM ANALYSIS
  • 5.7 TECHNOLOGY ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 6 COLLAGEN AND GELATIN MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF SUPPLIERS
    • 5.8.4 BARGAINING POWER OF BUYERS
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 REGULATORY ANALYSIS
    • 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10 PATENT ANALYSIS
    • FIGURE 26 PATENTS GRANTED FOR COLLAGEN MARKET, JUNE 2013-JUNE 2023
    • 5.10.1 LIST OF MAJOR PATENTS
    • FIGURE 27 PATENTS GRANTED FOR GELATIN MARKET, JUNE 2013-JUNE 2023
  • 5.11 KEY CONFERENCES AND EVENTS, 2023-2024
    • TABLE 12 COLLAGEN AND GELATIN MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • 5.12 PRICING ANALYSIS
    • 5.12.1 AVERAGE SELLING PRICE TREND ANALYSIS
    • TABLE 13 GELATIN MARKET: AVERAGE SELLING PRICE, BY SOURCE AND REGION, 2022-2023 (USD/KG)
    • TABLE 14 PORCINE GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019-2023 (USD/KG)
    • TABLE 15 BOVINE SKIN GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019-2023 (USD/KG)
    • TABLE 16 BOVINE BONE GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019-2023 (USD/KG)
    • TABLE 17 FISH & POULTRY GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019-2023 (USD/KG)
    • TABLE 18 OTHER ANIMAL SOURCES GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019-2023 (USD/KG)
    • TABLE 19 PLANT-SOURCED GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019-2023 (USD/KG)
  • 5.13 PRICING ANALYSIS
    • 5.13.1 AVERAGE SELLING PRICE TREND ANALYSIS
    • TABLE 20 BOVINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020-2022 (USD/TON)
    • TABLE 21 PORCINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020-2022 (USD/TON)
    • TABLE 22 POULTRY: AVERAGE SELLING PRICE (ASP), BY REGION, 2020-2022 (USD/TON)
    • TABLE 23 MARINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020-2022 (USD/TON)
    • TABLE 24 PLANT SOURCES: AVERAGE SELLING PRICE (ASP), BY REGION, 2020-2022 (USD/TON)
    • TABLE 25 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY MARKET PLAYERS, BY SOURCE, 2022 (USD/TON)
    • 5.13.2 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLLAGEN AND GELATIN PRODUCTS
    • 5.13.3 BUYING CRITERIA
    • FIGURE 29 KEY BUYING CRITERIA FOR END USERS

6 COLLAGEN AND GELATIN MARKET, BY SOURCE

  • 6.1 INTRODUCTION
    • TABLE 26 COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 27 GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • 6.2 BOVINE COLLAGEN AND GELATIN SOURCES
    • 6.2.1 INCREASED USE IN TISSUE ENGINEERING APPLICATIONS TO DRIVE MARKET
    • TABLE 28 BOVINE: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 29 NORTH AMERICA: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 EUROPE: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 31 ASIA PACIFIC: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 32 BOVINE: GELATIN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 33 NORTH AMERICA: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 EUROPE: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 35 ASIA PACIFIC: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 PORCINE COLLAGEN AND GELATIN SOURCES
    • 6.3.1 LOW ALLERGIC RESPONSE AND BIOCOMPATIBILITY OF PORCINE COLLAGEN AND GELATIN TO BOOST DEMAND
    • TABLE 36 PORCINE: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 37 NORTH AMERICA: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 EUROPE: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 ASIA PACIFIC: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 40 PORCINE: GELATIN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 41 NORTH AMERICA: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 EUROPE: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 ASIA PACIFIC: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 OTHER COLLAGEN AND GELATIN SOURCES
    • TABLE 44 OTHER SOURCES: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 45 NORTH AMERICA: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 46 EUROPE: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 OTHER SOURCES: GELATIN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 EUROPE: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 51 ASIA PACIFIC: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)

7 COLLAGEN MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 52 COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 7.2 ORTHOPEDIC
    • 7.2.1 INCREASING USE OF COLLAGEN IN ORTHOPEDIC SURGERIES TO DRIVE MARKET
    • TABLE 53 ORTHOPEDIC: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 54 NORTH AMERICA: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 EUROPE: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 56 ASIA PACIFIC: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 WOUND CARE
    • 7.3.1 RISING PREVALENCE OF CHRONIC WOUND CONDITIONS TO BOOST COLLAGEN ADOPTION
    • TABLE 57 WOUND CARE: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 58 NORTH AMERICA: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 EUROPE: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 ASIA PACIFIC: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 DENTAL
    • 7.4.1 RISING INCIDENCE OF ORAL DISORDERS TO DRIVE MARKET
    • TABLE 61 DENTAL: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 62 NORTH AMERICA: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 63 EUROPE: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 ASIA PACIFIC: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 SURGICAL
    • 7.5.1 INCREASING NUMBER OF SURGICAL PROCEDURES GLOBALLY TO BOOST DEMAND FOR COLLAGEN PRODUCTS
    • TABLE 65 SURGICAL: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 66 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 EUROPE: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 68 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.6 CARDIOVASCULAR
    • 7.6.1 GROWING USE OF COLLAGEN PATCHES TO IMPROVE HEART FUNCTION TO SUPPORT MARKET GROWTH
    • TABLE 69 CARDIOVASCULAR: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 70 NORTH AMERICA: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 EUROPE: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 72 ASIA PACIFIC: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.7 OTHER APPLICATIONS
    • TABLE 73 OTHER APPLICATIONS: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 74 NORTH AMERICA: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 EUROPE: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

8 GELATIN MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 77 GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 ORTHOPEDIC
    • 8.2.1 USE OF GELATIN IN BONE AND CARTILAGE REGENERATION TREATMENT TO DRIVE MARKET
    • TABLE 78 ORTHOPEDIC: GELATIN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 79 NORTH AMERICA: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 EUROPE: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 81 ASIA PACIFIC: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 WOUND CARE
    • 8.3.1 APPLICATION OF GELATIN-BASED HYDROGELS IN TREATING BURNS TO DRIVE MARKET
    • TABLE 82 WOUND CARE: GELATIN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 83 NORTH AMERICA: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 EUROPE: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 85 ASIA PACIFIC: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 OTHER APPLICATIONS
    • TABLE 86 OTHER APPLICATIONS: GELATIN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 87 NORTH AMERICA: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 EUROPE: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 ASIA PACIFIC: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 COLLAGEN AND GELATIN MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 90 COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 91 GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 HOSPITALS
    • 9.2.1 SIGNIFICANT USE OF BIOSURGERY PRODUCTS IN HOSPITALS
    • TABLE 92 HOSPITALS: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 93 NORTH AMERICA: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 94 EUROPE: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 96 HOSPITALS: GELATIN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 98 EUROPE: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 SURGICAL CENTERS
    • 9.3.1 AVAILABILITY OF HIGH-QUALITY AND LOW-COST MEDICAL SERVICES AT SURGICAL CENTERS
    • TABLE 100 SURGICAL CENTERS: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 101 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 102 EUROPE: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 103 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 104 SURGICAL CENTERS: GELATIN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 105 NORTH AMERICA: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 106 EUROPE: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 107 ASIA PACIFIC: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 COLLAGEN AND GELATIN MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 108 COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 109 GELATIN MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 30 NORTH AMERICA: COLLAGEN MARKET SNAPSHOT
    • TABLE 110 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 111 NORTH AMERICA: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 112 NORTH AMERICA: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 113 NORTH AMERICA: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • FIGURE 31 NORTH AMERICA: GELATIN MARKET SNAPSHOT
    • TABLE 114 NORTH AMERICA: GELATIN MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 115 NORTH AMERICA: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 116 NORTH AMERICA: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 117 NORTH AMERICA: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Increasing incidence of periodontitis and burn injuries to drive market
    • TABLE 118 US: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 119 US: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 120 US: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 121 US: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 122 US: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 123 US: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Growing geriatric population and volume of surgeries to boost collagen and gelatin demand
    • TABLE 124 CANADA: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 125 CANADA: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 126 CANADA: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 127 CANADA: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 128 CANADA: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 129 CANADA: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 RECESSION IMPACT ON MARKET IN NORTH AMERICA
  • 10.3 EUROPE
    • TABLE 130 EUROPE: COLLAGEN MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 131 EUROPE: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 132 EUROPE: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 133 EUROPE: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 134 EUROPE: GELATIN MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 135 EUROPE: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 136 EUROPE: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 137 EUROPE: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Increase in healthcare expenditure to boost adoption of collagen and gelatin products
    • TABLE 138 GERMANY: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 139 GERMANY: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 140 GERMANY: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 141 GERMANY: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 142 GERMANY: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 143 GERMANY: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 High risk of pressure ulcers in diabetic patients to drive market
    • TABLE 144 UK: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 145 UK: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 146 UK: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 147 UK: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 148 UK: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 149 UK: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Well-established healthcare sector to provide lucrative opportunities to collagen and gelatin vendors
    • TABLE 150 FRANCE: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 151 FRANCE: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 152 FRANCE: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 153 FRANCE: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 154 FRANCE: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 155 FRANCE: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 REST OF EUROPE
    • TABLE 156 REST OF EUROPE: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 157 REST OF EUROPE: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 158 REST OF EUROPE: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 159 REST OF EUROPE: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 160 REST OF EUROPE: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 161 REST OF EUROPE: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 RECESSION IMPACT ON MARKET IN EUROPE
  • 10.4 ASIA PACIFIC
    • FIGURE 32 ASIA PACIFIC: COLLAGEN MARKET SNAPSHOT
    • TABLE 162 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 163 ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 164 ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 165 ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • FIGURE 33 ASIA PACIFIC: GELATIN MARKET SNAPSHOT
    • TABLE 166 ASIA PACIFIC: GELATIN MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 167 ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 168 ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 169 ASIA PACIFIC: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Rising geriatric population to support market growth
    • TABLE 170 JAPAN: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 171 JAPAN: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 172 JAPAN: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 173 JAPAN: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 174 JAPAN: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 175 JAPAN: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Significant elderly population with diabetes to push demand for collagen and gelatin products
    • TABLE 176 CHINA: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 177 CHINA: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 178 CHINA: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 179 CHINA: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 180 CHINA: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 181 CHINA: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Increasing healthcare spending by government to stimulate market growth
    • TABLE 182 INDIA: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 183 INDIA: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 184 INDIA: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 185 INDIA: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 186 INDIA: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 187 INDIA: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 188 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 189 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 190 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 191 REST OF ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 192 REST OF ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 193 REST OF ASIA PACIFIC: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 RECESSION IMPACT ON MARKET IN ASIA PACIFIC
  • 10.5 REST OF THE WORLD (ROW)
    • TABLE 194 ROW: COLLAGEN MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 195 ROW: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 196 ROW: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 197 ROW: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 198 ROW: GELATIN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 199 ROW: GELATIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 200 ROW: GELATIN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.1 LATIN AMERICA
      • 10.5.1.1 Increasing number of diabetic patients to rise demand for collagen and gelatin products
    • TABLE 201 LATIN AMERICA: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 202 LATIN AMERICA: COLLAGEN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 203 LATIN AMERICA: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 RECESSION IMPACT ON MARKET IN LATIN AMERICA
    • 10.5.3 MIDDLE EAST & AFRICA
      • 10.5.3.1 Growing focus on healthcare infrastructure improvement to drive market
    • TABLE 204 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY SOURCE, 2021-2028 (USD MILLION)
    • TABLE 205 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.4 RECESSION IMPACT ON MARKET IN MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 34 COLLAGEN AND GELATIN MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 REVENUE SHARE ANALYSIS
    • FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2020-2022
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 36 COLLAGEN AND GELATIN MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
    • TABLE 206 COLLAGEN AND GELATIN MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    • FIGURE 37 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
  • 11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
    • 11.6.1 PRODUCT FOOTPRINT OF 25 COMPANIES
    • TABLE 207 COLLAGEN AND GELATIN MARKET: COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 11.6.2 REGIONAL FOOTPRINT OF 25 COMPANIES
    • TABLE 208 COLLAGEN AND GELATIN MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
  • 11.7 COMPANY EVALUATION MATRIX: START-UPS/SMES
    • FIGURE 38 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 STARTING BLOCKS
    • 11.7.3 RESPONSIVE COMPANIES
    • 11.7.4 DYNAMIC COMPANIES
  • 11.8 COMPETITIVE BENCHMARKING OF START-UP/SMES
    • TABLE 209 COLLAGEN AND GELATIN MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 210 COLLAGEN AND GELATIN MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • 11.9 COMPETITIVE SCENARIOS AND TRENDS
    • 11.9.1 PRODUCT LAUNCHES
    • TABLE 211 COLLAGEN AND GELATIN MARKET: PRODUCT LAUNCHES, JANUARY 2020-APRIL 2023
    • 11.9.2 DEALS
    • TABLE 212 COLLAGEN AND GELATIN MARKET: DEALS, JANUARY 2020-APRIL 2023

12 COMPANY PROFILES

  • 12.1 KEY MARKET PLAYERS
  • (Business Overview, Products offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 INTEGRA LIFESCIENCES
    • TABLE 213 INTEGRA LIFESCIENCES: COMPANY OVERVIEW
    • FIGURE 39 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
    • 12.1.2 DSM
    • TABLE 214 ROYAL DSM: COMPANY OVERVIEW
    • FIGURE 40 DSM: COMPANY SNAPSHOT
    • 12.1.3 NITTA GELATIN INC.
    • TABLE 215 NITTA GELATIN INC.: COMPANY OVERVIEW
    • FIGURE 41 NITTA GELATIN INC.: COMPANY SNAPSHOT
    • 12.1.4 COLLPLANT BIOTECHNOLOGIES LTD.
    • TABLE 216 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW
    • FIGURE 42 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT
    • 12.1.5 COLLAGEN SOLUTIONS PLC
    • TABLE 217 COLLAGEN SOLUTIONS PLC: COMPANY OVERVIEW
    • 12.1.6 REGENITY
    • TABLE 218 REGENITY: COMPANY OVERVIEW
    • 12.1.7 SYMATESE
    • TABLE 219 SYMATESE: COMPANY OVERVIEW
    • 12.1.8 GELITA AG
    • TABLE 220 GELITA AG: COMPANY OVERVIEW
    • TABLE 221 GELITA AG: DEALS
    • 12.1.9 TESSENDERLO GROUP (BU PB LINER)
    • TABLE 222 TESSENDERLO GROUP (BU PB LINER): COMPANY OVERVIEW
    • FIGURE 43 TESSENDERLO GROUP (BU PB LINER): COMPANY SNAPSHOT
    • TABLE 223 TESSENDERLO GROUP: DEALS
    • 12.1.10 SMITH & NEPHEW PLC
    • TABLE 224 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
    • FIGURE 44 SMITH & NEPHEW PLC: COMPANY SNAPSHOT
    • 12.1.11 ZIMVIE INC.
    • TABLE 225 ZIMVIE INC.: COMPANY OVERVIEW
    • 12.1.12 JELLAGEN
    • TABLE 226 JELLAGEN: COMPANY OVERVIEW
    • TABLE 227 JELLAGEN: PRODUCT OFFERINGS
  • 12.2 OTHER PLAYERS
    • 12.2.1 ADVANCED BIOMATRIX
    • 12.2.2 MATRICEL GMBH
    • 12.2.3 ROUSSELOT
    • 12.2.4 WEISHARDT
    • 12.2.5 XIAMEN HYFINE GELATIN CO., LTD.
    • 12.2.6 GEISTLICH PHARMA AG
    • 12.2.7 SYNERHEAL PHARMACEUTICALS
    • 12.2.8 BIOREGEN TECHNOLOGIES
    • 12.2.9 MERIL LIFE SCIENCES PVT. LTD.
    • 12.2.10 MEDSKIN SUWELACK
    • 12.2.11 COLOGENESIS HEALTHCARE PVT LTD
    • 12.2.12 DERMARITE INDUSTRIES, LLC
    • 12.2.13 EUCARE PHARMACEUTICALS PRIVATE LIMITED
  • *Details on Business Overview, Products offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS